Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines GlobeNewswire January 13, 2026 MIAMI, Jan. 13, 2026 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation oral macrocyclic MEK inhibitor for the treatment of neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN), […]

Restaurant Brands International Inc. (“RBI”, “the company”) (NYSE: QSR) (TSX: QSR) (TSX: QSP) today announced key 2026 dates, including an upcoming Investor Event on February 26, 2026 and preliminary 2026 earnings call dates. February 26, 2026 Investor Event The company will host an Investor Event in Miami, Florida on February 26, 2026. The event will

DUBAI, United Arab Emirates, Jan. 13, 2026 (GLOBE NEWSWIRE) — The first months of 2026 have produced a renewed interest in early-stage cryptocurrencies tied to real protocol deployment. Among the new entrants gaining attention is Mutuum Finance (MUTM). The project reports rising activity as its next phase approaches, and traders are watching how the token

(NASDAQ:SOTK), Seventh Consecutive Quarter of Revenue Over $5 Million Driven by Continued Strength in Medical Market and High-ASP Production Systems Gross Margin Expands to 50% in the Quarter and 51% Year-to-Date Third Quarter and Nine-Month Net Income Increased 24% and 32% Respectively Backlog Reaches Record $12.3 Million Reflecting Continued Order Momentum Reiterates Full Year FY

Company Expands Its Innovative Portfolio to Accelerate Advances in Diagnostics Synthego, a recognized leader in CRISPR solutions, announces its formal entry into the molecular and clinical diagnostic reagents sector. Building upon its reputation for rigorous quality, custom manufacturing, and innovation, Synthego’s significant expansion of its product portfolio empowers researchers, clinicians, and diagnostic laboratories with high-quality,

(NASDAQ:OCGN), MALVERN, Pa., Jan. 13, 2026 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast with KOLs and Ocugen executive leadership to discuss data from the first half of patients completing

(TSX:TDG), VANCOUVER, British Columbia, Jan. 13, 2026 (GLOBE NEWSWIRE) — TDG Gold Corp. (TSXV: TDG | OTCQX: TDGGF) (the “Company” or “TDG”) is pleased to report additional Phase I drilling results from the Aurora West Zone within TDG's Greater Shasta-Newberry (“GSN“) project located in the Toodoggone District of British Columbia. To date, the fully funded,

(NASDAQ:WATT), Energous reports preliminary revenue of approximately $5.6 million for the year ended December 31, 2025, representing more than 630% year-over-year growth and record annual revenue. For the quarter ended December 31, 2025, Energous reports preliminary revenue of approximately $3.0 million, compared to approximately $1.3 million in the previous quarter. Energous raised approximately $23.9 million

(TSX:AYA),(OTC US:AYASF),(Other OTC:AYASF), Production of 5 million silver equivalent ounces for the year, including the Boumadine tailings operation Record production of 545,491ounces at Zgounder for the month of December MONTREAL, Jan. 13, 2026 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce record quarterly

Ceva, Inc. (NASDAQ: CEVA), the leading licensor of silicon and software IP for the Smart Edge, will announce results for the fourth quarter and full year 2025 on February 17, 2026 before the NASDAQ market opens. Following the release, Ceva management will conduct a conference call at 8:30 a.m. Eastern Time to discuss the operating